Fund HoldingsKrensavage Asset Management, LLC

Total Portfolio Value
$180.9K
Total Bought
$38.5K
Total Sold
$22.5K
Net Transaction
+$16.1K
Filing Period:
Securities
SharesValue ($K)
Q4 2024
Q1 2025
Change
Q4 2024
Q1 2025
Weight (%)
Change
SUPERNUS PHARMACEUTICALS INC(SUPN)0431,986+431,9860147.82%+14
GSK PLC-SPON ADR(GSK)0272,000+272,0000115.83%+11
AVADEL PHARMACEUTICALS0950,000+950,000074.11%+7
VANDA PHARMACEUTICALS INC378,762754,381+375,619231.91%+2
CARDINAL HEALTH INC(CAH)208,845188,745-20,100252614.38%+1
SANOFI-ADR(SNY)149,196149,096-100784.57%+1
EXELIXIS INC(EXEL)965,866878,533-87,333323217.93%0
ALKERMES PLC(ALKS)238,136207,822-30,314773.79%0
MURAL ONCOLOGY PLC70,16370,263+100000.05%-0
ENANTA PHARMACEUTICALS INC2,117,3902,116,586-80412126.46%-0
JAZZ PHARMACEUTICALS PLC(JAZZ)105,803100,703-5,10013136.91%-1
BIONTECH SE-ADR(BNTX)88,66387,563-1,1001084.41%-2
UNITED THERAPEUTICS CORP(UTHR)92,05798,228+6,171323016.74%-2
INDIVIOR PLC935,680965,368+29,6881295.09%-2
BIOGEN INC(BIIB)108,9230-108,923170-17
Page 1 of 1